June Ann Seymour
CIK: 0002093716
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNAC
Cartesian Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Seymour June Ann
Seymour June Ann (SEC CIK 0002093716) files insider reports with the SEC as Chief Accounting Officer of Cartesian Therapeutics, Inc. (RNAC).
Signal8 holds 3 ownership filings by Seymour June Ann (1 Form 3, 2 Form 4), filed between Oct 28, 2025 and Jan 6, 2026. Those filings report 2 transactions, from Oct 27, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Seymour June Ann's filings is in FREDERICK, MD.
Recent filings by Seymour June Ann
Other insiders filing for Cartesian Therapeutics, Inc. (RNAC)
- Hoge Elizabeth, 10% Owner
- Kalayoglu Murat, 10% Owner
- Singer Michael, Director
- Brunn Carsten, President and CEO
- Miljkovic Milos, Chief Medical Officer
- Davis Blaine, Chief Financial Officer